title: Role of mouse hepatitis virus (MHV) receptor murine CEACAM1 in the resistance of mice to MHV infection: studies of mice with chimeric mCEACAM1a and mCEACAM1b.
abstract: Although most inbred mouse strains are highly susceptible to mouse hepatitis virus (MHV) infection, the inbred SJL line of mice is highly resistant to its infection. The principal receptor for MHV is murine CEACAM1 (mCEACAM1). Susceptible strains of mice are homozygous for the 1a allele of mCeacam1, while SJL mice are homozygous for the 1b allele. mCEACAM1a (1a) has a 10- to 100-fold-higher receptor activity than does mCEACAM1b (1b). To explore the hypothesis that MHV susceptibility is due to the different MHV receptor activities of 1a and 1b, we established a chimeric C57BL/6 mouse (cB61ba) in which a part of the N-terminal immunoglobulin (Ig)-like domain of the mCeacam1a (1a) gene, which is responsible for MHV receptor function, is replaced by the corresponding region of mCeacam1b (1b). We compared the MHV susceptibility of these chimeric mice to that of SJL and B6 mice. B6 mice that are homozygous for 1a are highly susceptible to MHV-A59 infection, with a 50% lethal dose (LD(50)) of 10(2.5) PFU, while chimeric cB61ba mice and SJL mice homozygous for 1ba and 1b, respectively, survived following inoculation with 10(5) PFU. Unexpectedly, cB61ba mice were more resistant to MHV-A59 infection than SJL mice as measured by virus replication in target organs, including liver and brain. No infectious virus or viral RNA was detected in the organs of cB61ba mice, while viral RNA and infectious virus were detected in target organs of SJL mice. Furthermore, SJL mice produced antiviral antibodies after MHV-A59 inoculation with 10(5) PFU, but cB61ba mice did not. Thus, cB61ba mice are apparently completely resistant to MHV-A59 infection, while SJL mice permit low levels of MHV-A59 virus replication during self-limited, asymptomatic infection. When expressed on cultured BHK cells, the mCEACAM1b and mCEACAM1ba proteins had similar levels of MHV-A59 receptor activity. These results strongly support the hypothesis that although alleles of mCEACAM1 are the principal determinants of mouse susceptibility to MHV-A59, other as-yet-unidentified murine genes may also play a role in susceptibility to MHV.
authors.affiliation: National Institute of Infectious Diseases, Murayama Branch, Gakuen, Musashi-Murayama, Tokyo 208-0011, Japan.
authors.forename: Asuka
authors.initials: A
authors.lastname: Hirai
authors.forename: Nobuhisa
authors.initials: N
authors.lastname: Ohtsuka
authors.forename: Toshio
authors.initials: T
authors.lastname: Ikeda
authors.forename: Rie
authors.initials: R
authors.lastname: Taniguchi
authors.forename: Dianna
authors.initials: D
authors.lastname: Blau
authors.forename: Keiko
authors.initials: K
authors.lastname: Nakagaki
authors.forename: Hideka S
authors.initials: HS
authors.lastname: Miura
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Ami
authors.forename: Yasuko K
authors.initials: YK
authors.lastname: Yamada
authors.forename: Shigeyoshi
authors.initials: S
authors.lastname: Itohara
authors.forename: Kathryn V
authors.initials: KV
authors.lastname: Holmes
authors.forename: Fumihiro
authors.initials: F
authors.lastname: Taguchi
mesh_terms: D000483:Alleles; D000818:Animals; D002272:Carcinoembryonic Antigen / Q000235:genetics / Q000378:metabolism*; D015815:Cell Adhesion Molecules; D006023:Glycoproteins / Q000235:genetics / Q000378:metabolism*; D006720:Homozygote; D007113:Immunity, Innate; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D006517:Murine hepatitis virus / Q000472:pathogenicity*; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D016019:Survival Analysis; D053586:Virus Internalization
chemical_list: D002272:Carcinoembryonic Antigen; C486183:Ceacam1 protein, mouse; C087701:Ceacam2 protein, mouse; D015815:Cell Adhesion Molecules; D006023:Glycoproteins; D011994:Recombinant Proteins
references.citation: J Immunol. 1986 Oct 1;137(7):2355-60
references.pmid: 3020124
references.citation: J Immunol. 1984 Jul;133(1):428-32
references.pmid: 6327825
references.citation: Infect Immun. 1981 Dec;34(3):1059-61
references.pmid: 6277785
references.citation: Trends Genet. 1994 Oct;10(10):365-71
references.pmid: 7985241
references.citation: J Virol. 1991 Dec;65(12):6881-91
references.pmid: 1719235
references.citation: J Clin Microbiol. 2002 Feb;40(2):372-5
references.pmid: 11825944
references.citation: J Virol. 1992 Dec;66(12):6931-8
references.pmid: 1279194
references.citation: Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12095-9
references.pmid: 8618851
references.citation: Lab Anim. 1997 Apr;31(2):97-115
references.pmid: 9175007
references.citation: Cell. 1991 Jun 28;65(7):1153-63
references.pmid: 2065352
references.citation: Infect Immun. 1980 Jul;29(1):42-9
references.pmid: 6156913
references.citation: J Virol. 1997 Nov;71(11):8860-3
references.pmid: 9343248
references.citation: Lab Invest. 1995 Nov;73(5):615-27
references.pmid: 7474935
references.citation: J Neurosci. 2007 Oct 3;27(40):10765-76
references.pmid: 17913910
references.citation: Int J Dev Biol. 1994 Jun;38(2):385-90
references.pmid: 7981049
references.citation: Proc Natl Acad Sci U S A. 1960 Aug;46(8):1065-75
references.pmid: 16590714
references.citation: J Virol. 2004 Sep;78(18):10156-65
references.pmid: 15331748
references.citation: Virology. 1997 Mar 17;229(2):336-48
references.pmid: 9126247
references.citation: J Virol. 2008 Jan;82(2):755-63
references.pmid: 18003729
references.citation: J Virol. 1995 Jan;69(1):543-6
references.pmid: 7983753
references.citation: J Virol. 1998 Mar;72(3):1941-8
references.pmid: 9499047
references.citation: J Infect Dis. 1991 Apr;163(4):879-82
references.pmid: 1849166
references.citation: Nucleic Acids Res. 1988 Feb 11;16(3):1215
references.pmid: 3344216
references.citation: Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1716-20
references.pmid: 8383324
references.citation: J Virol. 1994 Jan;68(1):1-5
references.pmid: 8254718
references.citation: Gene. 1993 May 30;127(2):173-83
references.pmid: 8500759
references.citation: Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5533-6
references.pmid: 1648219
references.citation: Curr Top Microbiol Immunol. 1981;92:25-52
references.pmid: 6171385
references.citation: Diabetes. 2008 Sep;57(9):2296-303
references.pmid: 18544705
references.citation: J Virol. 1992 Oct;66(10):6194-9
references.pmid: 1326665
references.citation: J Virol. 1996 Jun;70(6):3947-60
references.pmid: 8648732
references.citation: Exp Anim. 1998 Oct;47(4):261-4
references.pmid: 10067170
references.citation: Exp Cell Res. 1999 Nov 1;252(2):243-9
references.pmid: 11501563
references.citation: J Virol. 1994 Jul;68(7):4525-37
references.pmid: 8207827
references.citation: Cell Growth Differ. 1992 Mar;3(3):165-74
references.pmid: 1633107
references.citation: J Virol. 1989 Sep;63(9):3729-36
references.pmid: 2547994
references.citation: Genomics. 1991 Jul;10(3):583-7
references.pmid: 1653760
references.citation: J Virol. 2006 May;80(10):4901-8
references.pmid: 16641281
references.citation: Virology. 1993 Dec;197(2):732-41
references.pmid: 8249296
references.citation: Jpn J Microbiol. 1976 Aug;20(4):293-302
references.pmid: 185441
references.citation: J Gen Virol. 1996 Aug;77 ( Pt 8):1683-92
references.pmid: 8760415
references.citation: Eur J Biochem. 1995 Jul 1;231(1):104-14
references.pmid: 7628460
references.citation: J Virol. 2001 Sep;75(17):8173-86
references.pmid: 11483763
references.citation: J Virol. 2002 Feb;76(3):950-8
references.pmid: 11773370
references.citation: J Virol. 2004 Jan;78(1):216-23
references.pmid: 14671103
references.citation: Nature. 1996 Aug 22;382(6593):722-5
references.pmid: 8751444
references.citation: Adv Exp Med Biol. 2001;494:237-40
references.pmid: 11774475
references.citation: J Virol. 1993 Jan;67(1):1-8
references.pmid: 8380065
references.citation: J Virol. 1990 Aug;64(8):3817-23
references.pmid: 2164599
references.citation: J Virol. 1987 Jan;61(1):185-9
references.pmid: 3023696